Hong Yu Ah, Park Cheol Whee
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Antioxidants (Basel). 2021 Jan 18;10(1):130. doi: 10.3390/antiox10010130.
Reactive oxygen species and reactive nitrogen species are highly implicated in kidney injuries that include acute kidney injury, chronic kidney disease, hypertensive nephropathy, and diabetic nephropathy. Therefore, antioxidant agents are promising therapeutic strategies for kidney diseases. Catalytic antioxidants are defined as small molecular mimics of antioxidant enzymes, such as superoxide dismutase, catalase, and glutathione peroxidase, and some of them function as potent detoxifiers of lipid peroxides and peroxynitrite. Several catalytic antioxidants have been demonstrated to be effective in a variety of in vitro and in vivo disease models that are associated with oxidative stress, including kidney diseases. This review summarizes the evidence for the role of antioxidant enzymes in kidney diseases, the classifications of catalytic antioxidants, and their current applications to kidney diseases.
活性氧和活性氮与包括急性肾损伤、慢性肾病、高血压肾病和糖尿病肾病在内的肾脏损伤密切相关。因此,抗氧化剂是治疗肾脏疾病的有前景的策略。催化抗氧化剂被定义为抗氧化酶的小分子模拟物,如超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶,其中一些作为脂质过氧化物和过氧亚硝酸盐的有效解毒剂发挥作用。几种催化抗氧化剂已被证明在多种与氧化应激相关的体外和体内疾病模型(包括肾脏疾病)中有效。本综述总结了抗氧化酶在肾脏疾病中的作用、催化抗氧化剂的分类及其目前在肾脏疾病中的应用证据。